AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 50 filers reported holding AC IMMUNE SA in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $888,000 | +6.0% | 171,813 | 0.0% | 0.03% | 0.0% |
| Q3 2020 | $838,000 | -27.5% | 171,813 | 0.0% | 0.03% | -29.5% |
| Q2 2020 | $1,156,000 | -2.6% | 171,813 | 0.0% | 0.04% | -18.5% |
| Q1 2020 | $1,187,000 | -18.9% | 171,813 | 0.0% | 0.05% | -1.8% |
| Q4 2019 | $1,464,000 | +72.2% | 171,813 | 0.0% | 0.06% | +48.6% |
| Q3 2019 | $850,000 | -10.9% | 171,813 | 0.0% | 0.04% | -5.1% |
| Q2 2019 | $954,000 | +9.9% | 171,813 | 0.0% | 0.04% | +11.4% |
| Q1 2019 | $868,000 | -46.6% | 171,813 | 0.0% | 0.04% | -50.0% |
| Q4 2018 | $1,624,000 | +18.1% | 171,813 | 0.0% | 0.07% | +40.0% |
| Q3 2018 | $1,375,000 | -14.0% | 171,813 | 0.0% | 0.05% | -18.0% |
| Q2 2018 | $1,598,000 | -10.1% | 171,813 | 0.0% | 0.06% | -11.6% |
| Q1 2018 | $1,777,000 | -19.2% | 171,813 | 0.0% | 0.07% | -18.8% |
| Q4 2017 | $2,199,000 | +376.0% | 171,813 | +319.9% | 0.08% | +400.0% |
| Q3 2017 | $462,000 | – | 40,919 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,428,379 | $21,170,880 | 0.57% |
| Avidity Partners Management LP | 2,969,800 | $8,463,930 | 0.34% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,322,462 | $3,769,017 | 0.15% |
| Eversept Partners, LP | 124,589 | $355,079 | 0.03% |
| COHEN LAWRENCE B | 12,850 | $36,623 | 0.02% |
| Banque Cantonale Vaudoise | 80,701 | $231 | 0.01% |
| Renaissance Technologies | 425,179 | $1,212 | 0.00% |
| Handelsbanken Fonder AB | 101,064 | $288 | 0.00% |
| Tower Research Capital LLC (TRC) | 19,638 | $55,968 | 0.00% |
| Compagnie Lombard Odier SCmA | 10,000 | $28,500 | 0.00% |